Retatrutide 12mg is an experimental, once-weekly injectable triple-hormone receptor agonist (GIP, GLP-1, and glucagon) designed for significant weight loss, obesity management, and treating type 2 diabetes. It suppresses appetite, improves metabolic health, and has shown promising results in reducing body weight by up to 24% in trials.